首页> 美国卫生研究院文献>Netherlands Heart Journal >Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment
【2h】

Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment

机译:心律失常性右室发育不良/心肌病:诊断和治疗的新途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a heart muscle disorder of unknown course that is characterised pathologically by fatty or fibrofatty replacement of the right ventricular myocardium and electrical instability. Clinical manifestations include structural and functional malformations of the right ventricle, electrocardiographic abnormalities, and presentation of ventricular tachycardias with left bundle branch pattern or sudden death. The disease is often familial with an autosomal inheritance. In addition to right ventricular dilatation, right ventricular aneurysms are typical deformities of ARVD/C and they are distributed in the so-called 'triangle of dysplasia', i.e. the right ventricular outflow tract, apex and infundibulum. Ventricular aneurysms at these sites can be considered highly suggestive for ARVD/C. Another typical hallmark of ARVD/C is fatty or fibrofatty infiltration of the right ventricular free wall with potential extension to the left ventricle. These functional and morphological characteristics are relevant to clinical imaging investigations such as contrast angiography, echocardiography, radionuclide angiography, ultrafast-computed tomography and magnetic resonance (MR) imaging. Among these techniques, MR imaging allows the most comprehensive assessment of the heart, in particular because it provides functional and flow-dynamic information in addition to anatomic images. Furthermore, MR imaging offers the specific advantage of visualising adipose infiltration as a bright signal of the right ventricular myocardium.Non-pharmacological treatment by radio-frequency ablation and implantable defibrillators will play an increasing role in the treatment of patients with ARVD/C, especially in case of drug ineffectivity. Despite new diagnostic and therapeutic approaches in ARVD/C, there remain many unanswered issues since the current guidelines present criteria that are highly specific but lack sensitivity. Therefore, optimal assessment of diagnostic criteria would require a prospective evaluation from a large population obtained by an international registry.
机译:致心律失常性右心室发育不良/心肌病(ARVD / C)是一种未知病程的心肌病,其病理特征是右心室心肌的脂肪或纤维脂肪置换和电不稳定。临床表现包括右心室的结构和功能畸形,心电图异常以及表现为左束支型或猝死的室性心动过速。这种疾病通常是家族性的,具有常染色体遗传。除右心室扩张外,右心室动脉瘤是ARVD / C的典型畸形,它们分布在所谓的“发育异常三角区”,即右心室流出道,先端和漏斗。在这些部位的室性动脉瘤可被认为对ARVD / C高度提示。 ARVD / C的另一个典型标志是右心室游离壁的脂肪或纤维脂肪浸润,并可能延伸到左心室。这些功能和形态特征与临床成像研究有关,例如造影剂血管造影,超声心动图,放射性核素血管造影,超快速计算机断层扫描和磁共振(MR)成像。在这些技术中,MR成像可以对心脏进行最全面的评估,特别是因为它除了提供解剖图像外,还提供功能和血流动力学信息。此外,MR成像具有将脂肪浸润可视化为右心室心肌的亮信号的特殊优势。通过射频消融和植入式除纤颤器的非药物治疗将在ARVD / C患者的治疗中发挥越来越重要的作用以防药物无效。尽管在ARVD / C中采用了新的诊断和治疗方法,但是由于当前的指南提出的标准具有高度特异性但缺乏敏感性,因此仍然存在许多未解决的问题。因此,对诊断标准的最佳评估需要国际注册机构对大量人群进行前瞻性评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号